Abstract
BackgroundDue to the introduction of biological agents that inhibit the pro-inflammatory cytokines, IL-6 and TNF-α, remission has become a goal in the treatment of RA. Rheumatoid factor (RF) and the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
